SCHEMBL7064635

SCHEMBL7064635

Cc1ccc(S(=O)(=O)ON(N=Cc2ccc(F)c(Cl)c2)C(=N)N)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 1/20 0.38
ATM Q13315 1/20 0.37
ALDH1A1 P00352 10/20 0.36
MEN1 O00255 5/20 0.36
KMT2A Q03164 5/20 0.36
GAA P10253 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAPT P10636 8/20 0.35
TP53 P04637 2/20 0.35
LMNA P02545 5/20 0.34
HTT P42858 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PKM P14618 1/20 0.34
TSHR P16473 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7062964 0.92 GFER (0.38) GFERATMALDH1A1MEN1KMT2A
SCHEMBL7065660 0.88 ALDH1A1 (0.39) GFERATMALDH1A1MEN1KMT2A
SCHEMBL7064580 0.87 GFER (0.48) GFERALDH1A1MEN1KMT2AGAA
SCHEMBL7062979 0.86 GFER (0.38) GFERATMALDH1A1MEN1KMT2A
SCHEMBL7065388 0.84 ATM (0.38) GFERATMALDH1A1MEN1KMT2A
SCHEMBL7065198 0.82 ATM (0.45) GFERATMALDH1A1MEN1KMT2A
SCHEMBL7064632 0.80 ATM (0.38) ATMALDH1A1MEN1KMT2AGAA
SCHEMBL7064634 0.80 ATM (0.38) ATMALDH1A1MEN1KMT2AGAA
SCHEMBL7065233 0.80 PTGS2 (0.50) GFERATMALDH1A1MEN1KMT2A
SCHEMBL7062408 0.79 ALDH1A1 (0.39) GFERATMALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313461-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS Melacure Therapeutics AB (SE) 2003-05-28 EP claimed
WO-2002011715-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS MELACURE THERAPEUTICS AB (SE) 2002-02-14 WO claimed